enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Karuna Center for Peacebuilding - Wikipedia

    en.wikipedia.org/wiki/Karuna_Center_for_Peace...

    Karuna Center for Peacebuilding has collaborated with the SIT Graduate Institute in Brattleboro, Vermont, to teach courses in CONTACT (Conflict Transformation Across Cultures), a program that Dr. Paula Green founded in 1997 to provide intensive training and graduate certification in peacebuilding. [25]

  3. Steven M. Paul - Wikipedia

    en.wikipedia.org/wiki/Steven_M._Paul

    [19] [20] As of 2020, he was on the board of directors or is a trustee of several organizations, including serving as chairman of the Board of the Foundation for the NIH (FNIH) [21] and as a Director of Alnylam Pharmaceuticals, [22] Sage Therapeutics, [23] Voyager Therapeutics [24] and Karuna Pharmaceuticals. [25]

  4. Karuna-Shechen - Wikipedia

    en.wikipedia.org/wiki/Karuna-Shechen

    Karuna-Shechen is an international non-profit organization which provides health care, education, community development and women empowerment services in India, Nepal and Tibet. It was co-founded in 2000 by Matthieu Ricard , a French Buddhist monk and author, [ 1 ] and Shechen Rabjam Rinpoche, a Tibetan Buddhist monk.

  5. Karuna Therapeutics' Schizophrenia Drug Could Be a ... - AOL

    www.aol.com/karuna-therapeutics-schizophrenia...

    If Karuna is successful, its drug would offer relief to a large patient population. According to the World Health Organization, schizophrenia affects approximately 24 million people, or one in 300 ...

  6. Bristol Myers to buy schizophrenia drugmaker Karuna ...

    www.aol.com/news/bristol-myers-buy-schizophrenia...

    Karuna's drug is expected to be patent-protected in the United States through the mid-2030s. The deal is expected to hit Bristol Myers' earnings per share by roughly 30 cents in 2024 due to the ...

  7. Bristol Myers Squibb acquires Karuna Therapeutics for $14 ...

    www.aol.com/news/bristol-myers-squibb-acquires...

    Bristol Myers Squibb and Karuna announced their merger agreement on Friday. The transaction, which amounts to $330 per share in cash, offers a premium of 53% over Karuna's stock on Thursday.

  8. Xanomeline/trospium chloride - Wikipedia

    en.wikipedia.org/wiki/Xanomeline/trospium_chloride

    Xanomeline was licensed to Karuna Therapeutics in 2012 and KarXT was subsequently created as a dual drug formulation by adding trospium. Trospium is a non-brain-penetrant and non-selective muscarinic receptor blocker that may ameliorate the peripheral side effects of xanomeline.

  9. Top AI labs aren’t doing enough to ensure AI is safe, a ...

    www.aol.com/finance/top-ai-labs-aren-t-194819116...

    The institute recently tasked a team of outside experts to review the safety procedures and testing of the leading AI labs and found them all lacking. (Rita Franca—NurPhoto via Getty Images)